FLAME 30
166 Reports in Pharmaceuticals
Laboratory Automation Systems and Processes: Global Markets and T...
The global market for laboratory automation systems and processes should grow from $21.1 billion in 2018 to reach $29.2 billion by 2023 at a compound annual growth rate (CAGR) of 6.8% for the period of 2018-2023.
In Vitro Toxicity Testing: Technologies and Global Markets
The global market for in vitro toxicity testing should grow from $7.4 billion in 2018 to reach $10.4 billion by 2023 at a compound annual growth rate (CAGR) of 7.1% for the period of 2018-2023.
High-Throughput Screening: Technologies and Global Markets
The global high-throughput screening (HTS) market should reach $21.1 billion by 2023 from $14.4 billion in 2018 at a compound annual growth rate (CAGR) of 7.9% for the period 2018-2023.
Blood Cancer Therapeutics: Global Markets to 2023
The global market for blood cancer therapeutics should grow from $38.5 billion in 2018 to $64.8 billion by 2023 at a compound annual growth rate (CAGR) of 11.0% from 2018 to 2023.
Brain Tumor Therapeutics: Global Markets to 2023
The global market for brain tumor therapeutics should grow from $1.1 billion in 2018 to reach $2.0 billion by 2023 at a compound annual growth rate (CAGR) of 12.9% for the period of 2018-2023.
Global Cancer Therapeutics Market: Emphasis on Recurrent and Meta...
The global cancer therapeutics market should grow from $128.1 billion in 2018 to $182.0 billion by 2023 at a compound annual growth rate (CAGR) of 7.3% for the period of 2018-2023.
Global Market for Contract Research Organization (CRO) Services
The global market for CRO's across the clinical trial process should grow from $45.5 billion in 2017 to reach $72.3 billion by 2022 at a compound annual growth rate (CAGR) of 9.7% for the period of 2017-2022.
Opioid Drugs: Global Markets to 2023
The global market for opioid drugs should reach $29.8 billion by 2023 from $26.4 billion in 2018 at a compound annual growth rate (CAGR) of 2.5% for the period of 2018-2023.
Antibiotics: Global Markets to 2023
The global antibiotics market should reach $55.8 billion by 2023 from $38.3 billion in 2018 at a compound annual growth rate (CAGR) of 7.8% for the period of 2018-2023.
Lung Cancer Therapeutics: Global Markets
The global market for lung cancer therapeutics should grow from $17.9 billion in 2018 to $26.3 billion by 2023, increasing at a compound annual growth rate (CAGR) of 8.0% from 2018 to 2023.
Diagnostics and Therapeutics for HIV: Global Markets
The global HIV therapeutics market should reach $27.1 billion by 2023 from $22.0 billion in 2018 at a compound annual growth rate (CAGR) of 4.3% for the period of 2018 to 2023.
Checkpoint Inhibitors: Global Markets
The global checkpoint inhibitors market should reach $29.3 billion by 2023 from $14.9 billion in 2018 at a compound annual growth rate (CAGR) of 14.4% for the period of 2018-2023.
Global Viral Vector Manufacturing Markets and Technologies Throug...
The global market for viral vector vaccine manufacturing is expected to increase from $22.9 million in 2017 to nearly $51.2 million in 2022 at a compound annual growth rate (CAGR) of 17.5% for 2017-2022.
Antipsychotic Drugs: Technologies and Global Markets
The global market for antipsychotic drugs should grow from $13.2 billion in 2018 to reach $14.5 billion by 2023 at a compound annual growth rate (CAGR) of 1.9% for the period of 2018-2023.
Lysosomal Disease Treatments: Technologies and Global Markets
The global market for lysosomal storage diseases treatment should grow from $5.1 billion in 2018 to reach $7.6 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.
Global Markets for Treatment and Diagnosis of Sexually Transmitte...
The global market for sexually transmitted disease therapeutics reached $52.0 billion in 2018 and should reach nearly $63.0 billion by 2023, at a compound annual growth rate (CAGR) of 3.9% for the period of 2018-2023.
Antiemetics: Technologies and Global Markets
The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.
Pharmaceuticals for Women's Health: Global Markets to 2023
The global market for women’s health therapeutics reached nearly $30.5 billion in 2018 and should reach nearly $37.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.2% for the period of 2018-2023.
Cognition and Memory Enhancement Drugs: Technologies and Global M...
The global cognition and memory-enhancing drugs market should reach over $4.2 billion by 2022 from $2.8 billion in 2017 at a compound annual growth rate (CAGR) of 8.7% for the period 2017-2022.
Active Pharmaceutical Ingredients: Global Markets to 2022
The global active pharmaceutical ingredient (API) market should reach $154.7 billion by 2022 from $114.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.2% for the period 2017-2022.
Neuroprotective Agents: Therapeutic Applications and Global Marke...
The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.
Antiulcerant Drugs: Global Markets to 2022
The global antiulcerant drugs market will grow from $33.0 billion in 2017 to $37.4 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.
Clinical Nutrition: Global Markets to 2022
The global clinical nutrition market should reach $60.8 billion by 2022 from $48.2 billion in 2017 at a compound annual growth rate (CAGR) of 4.8% for the period 2017-2022.
The Global Influenza Market
The global influenza market was valued at nearly $5.6 billion in 2017 and is expected to reach nearly $6.5 billion by 2022, increasing at a compound annual growth rate (CAGR) of 3.0% from 2017 through 2022.
Choose your License
8 Upcoming Reports in Pharmaceuticals
Global Research and Development Investments in Over-the-Counter (OTC) Drugs and Nutraceuticals
Report Includes
- An overview of the global research and development investments in over-the-counter (OTC) drugs and nutraceuticals.
- Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- Discussion of the strategies and plans behind research-and-development activities.
- Estimation of investments in R&D activities in OTC drugs by therapeutic classification, routes of OTC drug administration, companies, institutions, and regions.
- Macro- and micro-level scenarios, insights, and analyses of global R&D initiatives around OTC drugs.
- Company profiles of key players in the industry based on their market shares, product offerings, and regions.
Pharmaceutical Pricing and Reimbursement: Global Markets
Report Includes
- An overview of the global markets for pharmaceuticals, specifically healthcare legislation and regulation, pricing mechanisms, and reimbursement procedures.
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- Information on the current price and reimbursement landscape, benchmarking statics, and future development opportunities in the pharma industry.
- Case studies of different price and reimbursement strategies for prescription drugs, generics, biosimilars, hospitals, and over-the-counter products.
- Coverage of market dynamics, specifically growth drivers, restraints, and opportunities.
- Comprehensive company profiles of major players in the industry.
Global Markets for Generic Drugs
Report Includes
- An overview of the global markets for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD.
- Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023.
- Examination of strategies employed by companies specializing in generics to meet the challenges of this highly competitive market, while also summarizing strategies employed by “originator” companies to forestall generic competition.
- Discussion of important trends by product categories and major country markets, acknowledging that Brazil, China, India, Mexico, and Russia are among the rising markets for generic activity.
- Profiles of major players and leading generics companies.
- A look at recent merger-and-acquisition activity.
Drug Testing: Technologies and Global Markets
Report Includes
- An industry analysis of the global market for drug testing technologies within the pharmaceutical industry
- Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Statistical information pertaining to drug abuse along with its trends as well as drug classes in key geographic regions
- Information on leading players in the market and their key products
- Sales projections through 2023 for drug of abuse testing markets by sample matrix and geographic regions
- Technological assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and examines the influence of these acts in the development of the industry
- Company profiles of major global players operating within the drug development market
Laboratory animal models, 3D cultures and organoids
Report Includes
- Country specific data and analysis for USA, Canada, Brazil, Chile, UK, Germany , France, China, India, Japan, Australia, Israel, Turkey and South Africa
- Detailed description about animal models, 3D cultures and organoids and their potential applications
- Discussion about the main industry drivers and opportunities with detailed focus on the current and future trends in science and technology
- Company profiles of major players in the market
